1. Evolutionary dynamics of residual disease in human glioblastoma. (19th November 2018) Authors: Spiteri, I; Caravagna, G; Cresswell, G D; Vatsiou, A; Nichol, D; Acar, A; Ermini, L; Chkhaidze, K; Werner, B; Mair, R; Brognaro, E; Verhaak, R G W; Sanguinetti, G; Piccirillo, S G M; Watts, C; Sottoriva, A Journal: Annals of oncology Issue: Volume 30:Number 3(2019) Page Start: 456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. JS08.7.A Integrative analysis of longitudinal genomic and non-genetic mechanisms of radiotherapy-resistance in glioma. (5th September 2022) Authors: Kocakavuk, E; Varn, F S; Johnson, K C; Verhaak, R G W Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PL03.2.A Radiotherapy is associated with a deletion signature that contributes to poor outcomes in glioma patients. (9th September 2021) Authors: Kocakavuk, E; Anderson, K J; Varn, F S; Johnson, K C; Amin, S B; Sulman, E P; Lolkema, M P; Barthel, F P; Verhaak, R G W Journal: Neuro-oncology Issue: Volume 23: Supplement 2 (2021) Page Start: ii2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗